Mechanisms of action of retinal microglia in diabetic retinopathy (Review)
International Journal of Molecular Medicine · 2025
DOI: 10.3892/ijmm.2025.5643 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2025. Verfasst von Yuyang Bai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Third Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750001, P.R. China. Hauptthemen laut MEDLINE: Microglia, Diabetic Retinopathy, Retina. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Diabetic retinopathy (DR), a leading cause of blindness in diabetic microvascular complications, is pathologically associated with the dynamic regulation of retinal microglia. The present review systematically elucidated the dual roles of microglia in DR pathogenesis. Under physiological conditions, microglia maintain blood‑retinal barrier (BRB) integrity by phagocytosing metabolic debris and secreting neurotrophic factors. However, hyperglycaemic stress induces pathological M1 polarization, triggering a cytokine storm (TNF‑α and IL‑1β) via the Toll‑like receptor 4/myeloid differentiation primary response 88/NF‑κB signalling axis, which synergizes with proangiogenic factors (such as VEGF and insulin‑like growth factor 1) to exacerbate BRB breakdown and pathological neovascularization. Notably, activated microglia amplify inflammatory cascades through astrocyte‑Müller cell interaction networks, accelerating neurovascular unit dysfunction. Emerging therapeutic strategies targeting microglial polarization homeostasis (such as promoting M2 anti‑inflammatory phenotypic shifts) and blocking critical inflammatory signalling pathways present novel opportunities for developing multitarget therapeutic agents with combined neuroprotective and anti‑vasopermeability properties. By elucidating microglial heterogeneity and intercellular regulatory networks, the present review highlighted the importance of precise modulation of immune homeostasis in DR management, providing a theoretical foundation for overcoming the limitations of single‑target therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Third Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750001, P.R. China.
- Department of Ophthalmology, Ningxia Eye Hospital, People's Hospital of Ningxia Hui Autonomous Region, Third Clinical School of Medicine, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750001, P.R.…
Zitieren
APA
Bai, Y., Wang, X., Qi, F., Zuo, X., & Zou, G. (2025). Mechanisms of action of retinal microglia in diabetic retinopathy (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5643
Vancouver
Bai Y, Wang X, Qi F, Zuo X, Zou G. Mechanisms of action of retinal microglia in diabetic retinopathy (Review). International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5643
BibTeX
@article{Bai2025,
author = {Bai, Yuyang and Wang, Xinrong and Qi, Fan and Zuo, Xiaoyang and Zou, Gang},
title = {Mechanisms of action of retinal microglia in diabetic retinopathy (Review)},
journal = {International Journal of Molecular Medicine},
year = {2025},
doi = {10.3892/ijmm.2025.5643}
}
EUVIMED